Bionomics (BNOX) Competitors $0.29 +0.02 (+7.28%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends BNOX vs. MEIP, PRPH, ENLV, FNCH, CGTX, NNVC, BFRG, FLGC, MRNS, and CARAShould you be buying Bionomics stock or one of its competitors? The main competitors of Bionomics include MEI Pharma (MEIP), ProPhase Labs (PRPH), Enlivex Therapeutics (ENLV), Finch Therapeutics Group (FNCH), Cognition Therapeutics (CGTX), NanoViricides (NNVC), Bullfrog AI (BFRG), Flora Growth (FLGC), Marinus Pharmaceuticals (MRNS), and Cara Therapeutics (CARA). These companies are all part of the "pharmaceutical products" industry. Bionomics vs. MEI Pharma ProPhase Labs Enlivex Therapeutics Finch Therapeutics Group Cognition Therapeutics NanoViricides Bullfrog AI Flora Growth Marinus Pharmaceuticals Cara Therapeutics Bionomics (NASDAQ:BNOX) and MEI Pharma (NASDAQ:MEIP) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, media sentiment, profitability, risk, community ranking, earnings, analyst recommendations, dividends and valuation. Do institutionals and insiders believe in BNOX or MEIP? 15.9% of Bionomics shares are owned by institutional investors. Comparatively, 52.4% of MEI Pharma shares are owned by institutional investors. 0.7% of Bionomics shares are owned by insiders. Comparatively, 3.9% of MEI Pharma shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the media refer more to BNOX or MEIP? In the previous week, Bionomics had 1 more articles in the media than MEI Pharma. MarketBeat recorded 2 mentions for Bionomics and 1 mentions for MEI Pharma. Bionomics' average media sentiment score of 0.30 beat MEI Pharma's score of 0.00 indicating that Bionomics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bionomics 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral MEI Pharma 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has higher valuation & earnings, BNOX or MEIP? MEI Pharma has higher revenue and earnings than Bionomics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBionomics$10K510.18-$15.49MN/AN/AMEI Pharma$65.30M0.28$17.78M-$6.99-0.40 Do analysts rate BNOX or MEIP? Bionomics presently has a consensus price target of $8.00, suggesting a potential upside of 2,615.92%. MEI Pharma has a consensus price target of $7.00, suggesting a potential upside of 151.80%. Given Bionomics' stronger consensus rating and higher possible upside, research analysts plainly believe Bionomics is more favorable than MEI Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bionomics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00MEI Pharma 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is BNOX or MEIP more profitable? Bionomics' return on equity of 0.00% beat MEI Pharma's return on equity.Company Net Margins Return on Equity Return on Assets BionomicsN/A N/A N/A MEI Pharma N/A -84.80%-65.24% Which has more risk and volatility, BNOX or MEIP? Bionomics has a beta of -0.07, meaning that its share price is 107% less volatile than the S&P 500. Comparatively, MEI Pharma has a beta of 0.83, meaning that its share price is 17% less volatile than the S&P 500. Does the MarketBeat Community prefer BNOX or MEIP? MEI Pharma received 380 more outperform votes than Bionomics when rated by MarketBeat users. However, 76.92% of users gave Bionomics an outperform vote while only 62.02% of users gave MEI Pharma an outperform vote. CompanyUnderperformOutperformBionomicsOutperform Votes2076.92% Underperform Votes623.08% MEI PharmaOutperform Votes40062.02% Underperform Votes24537.98% SummaryBionomics beats MEI Pharma on 9 of the 15 factors compared between the two stocks. Ad StockEarningsPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely to lose big time now that Donald Trump has been re-electedClaim your copy before they move Get Bionomics News Delivered to You Automatically Sign up to receive the latest news and ratings for BNOX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BNOX vs. The Competition Export to ExcelMetricBionomicsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.10M$6.57B$5.23B$8.84BDividend YieldN/A8.13%5.53%4.08%P/E RatioN/A10.0292.4617.55Price / Sales510.18360.321,237.1695.89Price / CashN/A53.8341.4336.94Price / Book0.3010.597.236.54Net Income-$15.49M$153.02M$119.89M$226.07M7 Day Performance1.19%3.96%2.14%3.77%1 Month Performance-18.20%-6.72%-2.23%4.46%1 Year Performance-83.07%30.92%32.63%27.57% Bionomics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BNOXBionomics2.6017 of 5 stars$0.29+7.3%$8.00+2,615.9%-84.6%$5.10M$10,000.000.00N/AMEIPMEI Pharma3.9243 of 5 stars$2.81+0.4%$7.00+149.1%-55.0%$18.72M$65.30M-0.40100Analyst ForecastPRPHProPhase Labs3.338 of 5 stars$0.78+1.3%$11.00+1,315.9%-82.7%$18.55M$44.38M-0.62130Negative NewsHigh Trading VolumeENLVEnlivex Therapeutics3.2325 of 5 stars$0.86-11.3%$6.00+595.7%-49.2%$18.47MN/A-0.7370Positive NewsHigh Trading VolumeFNCHFinch Therapeutics GroupN/A$11.45flatN/A+225.7%$18.43M$110,000.00-1.30190CGTXCognition Therapeutics2.53 of 5 stars$0.43-2.3%$8.00+1,741.6%-55.4%$18.05MN/A-0.4520Negative NewsNNVCNanoViricidesN/A$1.28-3.8%N/A+23.5%$17.85MN/A-1.7420BFRGBullfrog AIN/A$2.02flatN/A-35.4%$17.60M$60,000.00-2.374Gap UpFLGCFlora Growth2.11 of 5 stars$1.31+7.4%$6.00+358.0%+92.3%$17.52M$76.07M0.00280MRNSMarinus Pharmaceuticals4.474 of 5 stars$0.31flat$4.79+1,444.3%-94.7%$17.05M$31.47M-0.13110CARACara Therapeutics3.7246 of 5 stars$0.31+3.3%$2.32+648.4%-68.3%$16.73M$8.69M-0.1855Analyst Forecast Related Companies and Tools Related Companies MEIP Competitors PRPH Competitors ENLV Competitors FNCH Competitors CGTX Competitors NNVC Competitors BFRG Competitors FLGC Competitors MRNS Competitors CARA Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BNOX) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredA “Thank You Gift” From Pres. Trump - GeniusTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bionomics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Bionomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BNOX Stock Alerts